M.D., Ph.D.
Arthur D. Riggs Distinguished Chair in Diabetes & Metabolism Research; Professor and Chair, Department of Translational Research & Cellular Therapeutics
Fouad Kandeel, M.D., Ph.D., is the Arthur D. Riggs Distinguished Chair in Diabetes & Metabolism Research and the chair of the Department of Translational Research & Cellular Therapeutics at City of Hope® Cancer Center Duarte. He also runs the Diabetes and Cardiovascular Risk Reduction Program, which he founded to help patients better manage their health and lower their risk of heart health issues related to diabetes.
As a clinical provider, Dr. Kandeel’s goal is to bring the latest advances in diabetes and cancer care to his patients, combining leading-edge research with personalized, compassionate care. With extensive experience in treating endocrine tumors and thyroid cancer, Dr. Kandeel also contributes to creating national care guidelines for these conditions.
In his research work, Dr. Kandeel is the lead investigator on a crucial clinical trial that is seeking to determine whether islet cell transplantation is a safe and effective treatment for type 1 diabetes. He also recently completed a clinical project focused on finding genes that may increase the risk of type 2 diabetes and heart disease in Hispanic communities.